KALA BIO (KALA)

Last close As at 15/08/2025

USD8.32

0.25 (3.10%)

Market capitalisation

USD59m

KALA BIO is a clinical-stage biotechnology company advancing its proprietary mesenchymal stem cell secretome (MSC-S) platform towards rare eye diseases, with lead candidate KPI-012 targeting ocular surface diseases.

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Todd Bazemore

    CEO

  • Mary Reumuth

    CFO

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free